Clinical Trial Update: Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related Comorbidity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on AZD5004 in adults with obesity or overweight and at least one weight-related comorbidity; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• AZD5004 (AZD5004)

Snippet

Sponsor: AstraZeneca | Conditions: Obesity or Overweight | Phase 2 | Status: COMPLETED